[DPHARMA] YoY Quarter Result on 31-Dec-2017 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
28-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Dec-2017 [#4]
Profit Trend
QoQ- 4.08%
YoY- 40.84%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 134,086 137,755 115,634 112,253 74,033 89,401 51,024 17.45%
PBT 20,471 13,939 17,658 12,825 6,299 17,529 13,921 6.63%
Tax -4,278 -1,906 -3,289 -1,057 2,532 0 0 -
NP 16,193 12,033 14,369 11,768 8,831 17,529 13,921 2.54%
-
NP to SH 16,193 12,033 14,369 11,870 8,428 15,335 11,119 6.45%
-
Tax Rate 20.90% 13.67% 18.63% 8.24% -40.20% 0.00% 0.00% -
Total Cost 117,893 125,722 101,265 100,485 65,202 71,872 37,103 21.22%
-
Net Worth 642,484 525,364 483,173 479,809 454,703 270,177 192,951 22.17%
Dividend
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 42,361 34,114 26,475 16,737 11,158 9,172 20,128 13.19%
Div Payout % 261.60% 283.51% 184.25% 141.01% 132.40% 59.82% 181.02% -
Equity
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 642,484 525,364 483,173 479,809 454,703 270,177 192,951 22.17%
NOSH 706,026 684,383 661,881 278,959 278,959 278,959 138,813 31.10%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 12.08% 8.74% 12.43% 10.48% 11.93% 19.61% 27.28% -
ROE 2.52% 2.29% 2.97% 2.47% 1.85% 5.68% 5.76% -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 18.99 20.19 17.47 40.24 26.54 53.61 36.76 -10.41%
EPS 2.29 1.76 2.17 4.22 3.41 9.19 8.01 -18.81%
DPS 6.00 5.00 4.00 6.00 4.00 5.50 14.50 -13.66%
NAPS 0.91 0.77 0.73 1.72 1.63 1.62 1.39 -6.81%
Adjusted Per Share Value based on latest NOSH - 278,959
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 13.93 14.31 12.01 11.66 7.69 9.29 5.30 17.45%
EPS 1.68 1.25 1.49 1.23 0.88 1.59 1.16 6.36%
DPS 4.40 3.54 2.75 1.74 1.16 0.95 2.09 13.19%
NAPS 0.6674 0.5457 0.5019 0.4984 0.4723 0.2807 0.2004 22.18%
Price Multiplier on Financial Quarter End Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 3.38 1.42 0.95 2.53 1.98 2.62 2.50 -
P/RPS 17.80 7.03 5.44 6.29 7.46 4.89 6.80 17.37%
P/EPS 147.37 80.52 43.76 59.46 65.54 28.49 31.21 29.49%
EY 0.68 1.24 2.29 1.68 1.53 3.51 3.20 -22.73%
DY 1.78 3.52 4.21 2.37 2.02 2.10 5.80 -17.85%
P/NAPS 3.71 1.84 1.30 1.47 1.21 1.62 1.80 12.79%
Price Multiplier on Announcement Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 22/02/21 13/02/20 18/02/19 28/02/18 24/02/17 23/02/16 24/02/15 -
Price 3.42 1.64 1.03 2.97 2.23 2.61 2.92 -
P/RPS 18.01 8.12 5.90 7.38 8.40 4.87 7.94 14.61%
P/EPS 149.11 92.99 47.45 69.80 73.81 28.39 36.45 26.43%
EY 0.67 1.08 2.11 1.43 1.35 3.52 2.74 -20.90%
DY 1.75 3.05 3.88 2.02 1.79 2.11 4.97 -15.95%
P/NAPS 3.76 2.13 1.41 1.73 1.37 1.61 2.10 10.18%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment